Kanada - enska - Health Canada

mint pharmaceuticals inc - frovatriptan (frovatriptan succinate) - tablet - 2.5mg - frovatriptan (frovatriptan succinate) 2.5mg - selective serotonin agonists

Kanada - enska - Health Canada

sanis health inc - frovatriptan (frovatriptan succinate) - tablet - 2.5mg - frovatriptan (frovatriptan succinate) 2.5mg

Kanada - enska - Health Canada

endo pharmaceuticals inc. - frovatriptan (frovatriptan succinate) - tablet - 2.5mg - frovatriptan (frovatriptan succinate) 2.5mg - selective serotonin agonists

Kanada - franska - Health Canada

jamp pharma corporation - frovatriptan (succinate de frovatriptan monohydraté) - comprimé - 2.5mg - frovatriptan (succinate de frovatriptan monohydraté) 2.5mg - selective serotonin agonists

Bandaríkin - enska - NLM (National Library of Medicine)

endo pharmaceuticals, inc. - frovatriptan succinate (unii: d28j6w18hy) (frovatriptan - unii:h82q2d5wa7) - frovatriptan 2.5 mg - frova is indicated for the acute treatment of migraine with or without aura in adults. limitations of use - use only if a clear diagnosis of migraine has been established. if a patient has no response for the first migraine attack treated with frova, reconsider the diagnosis of migraine before frova is administered to treat any subsequent attacks. use only if a clear diagnosis of migraine has been established. if a patient has no response for the first migraine attack treated with frova, reconsider the diagnosis of migraine before frova is administered to treat any subsequent attacks. - frova is not indicated for the prevention of migraine attacks. frova is not indicated for the prevention of migraine attacks. - safety and effectiveness of frova have not been established for cluster headache. safety and effectiveness of frova have not been established for cluster headache. frova is contraindicated in patients with: - ischemic coronary artery disease (cad) (e.g., angina pectoris, history of myocardial

Holland - hollenska - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

doc generici s.r.l. via filippo turati 40 20121 milano (italiË) - frovatriptan succinaat 1-water 3,9 mg/stuk samenstelling overeenkomend met ; frovatriptan 2,5 mg/stuk - filmomhulde tablet - cellulose, microkristallijn (e 460(i)) ; glyceroltriacetaat (e 1518) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; lactose 0-water ; lactose 1-water ; macrogol 3350 ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat ; siliciumdioxide (e 551) ; titaandioxide (e 171), cellulose, microkristallijn (e 460) ; glyceroltriacetaat (e 1518) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; lactose 0-water ; lactose 1-water ; macrogol 3350 ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat ; siliciumdioxide (e 551) ; titaandioxide (e 171), cellulose, microkristallijn (e 460) ; glyceroltriacetaat (e 1518) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; lactose 0-water ; lactose 1-water ; macrogol 3350 ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat (e468) ; siliciumdioxide (e 551) ; titaandioxide (e 171), - frovatriptan

Bandaríkin - enska - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - frovatriptan succinate (unii: d28j6w18hy) (frovatriptan - unii:h82q2d5wa7) - frovatriptan succinate 2.5 mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - frovatriptan succinate monohydrate - oral tablet - 2.5mg

Írland - enska - HPRA (Health Products Regulatory Authority)

pco manufacturing ltd. - frovatriptan succinate monohydrate - film-coated tablet - 2.5 milligram(s) - selective serotonin (5ht1) agonists; frovatriptan

Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

mylan pharmaceuticals limited - frovatriptansuccinat monohydrate - filmovertrukne tabletter - 2,5 mg